Introduction
In recent years, Candida species have emerged as major causes of infections among patients with serious underlying diseases such as hematological malignancies or critically ill patients hospitalized in Intensive Care Units (ICUs). Those infections have raised concerns as a result of high mortality rates and medical costs [1, 2] . Candida spp. are the fourth leading cause of nosocomial bloodstream infections (BSIs) in the United States (US) and sixth in Turkey [3 -5] . The incidence of candidemia per 1,000 admissions varies between 0.17 (in general hospitals) and 20 (in ICU patients) in European countries [6] . It ranges from 6 -24 per 100,000 population per year in US [2] . In a study conducted between 2000 and 2003 in our country, it was found Candida species, which was one of the aims of our study, can provide guidance in deciding on empirical anticandidal therapy.
In Turkey, there are limited reports documenting the spectrum of yeasts responsible for candidemia and risk factors, therefore we conducted an observational, multi-center, case-control study to investigate causative agents and risk factors of candidemia in adult patients at six tertiary-care educational hospitals.
Methods

Study design and patient selection
An observational, prospective, case-control study was conducted from February 2008 to the end of January 2009 with the aim of analyzing Candida species causing candidemia and their risk factors in six Turkish tertiary-care educational hospitals. The study included patients older than 18 years of age with Candida BSIs, the latter being defi ned as isolation of any species of Candida in at least one blood culture of patients who presented with clinical signs or symptoms of infection [10] . We randomly selected at least two control patients for each case who were matched according to the age groups hospitalized in the same hospital in the same period with no signs and symptoms of candidemia and with negative blood cultures for Candida spp.
Data collection
Study team members from each hospital collected demographic and clinical data by reviewing patients ' medical reports. Since the study was an observational noninterventional investigation, all decisions regarding patient management including the diagnostic tests and antifungal treatment were made by the patients ' physicians and not by the research team members. The case group data used for risk factor analyses were collected up to the time of the development of candidemia and the data for controls were collected up to the same day. Risk factors for the last 30 days prior to onset of candidemia were assessed. The parameters collected for each case and controls included age, gender, length of stay (LOS) in the hospital. In addition, we considered the presence of predisposing factors such as diabetes mellitus, chronic renal failure, chronic obstructive pulmonary disease (COPD), malignancy, organ transplantation, surgical procedures, presence of central venous (CVC) or urethral catheters, mechanical ventilation, red blood cell (RBC) transfusion, administration of total parenteral nutrition (TPN), anticancer chemotherapy, steroids, antibiotics and antifungals. The Eastern Cooperative Oncology Group (ECOG) Performance Status was used to assess the patient ' s daily living abilities [11] .
Identifi cation of species
Blood cultures were processed at each of the hospitals participating in the study by an automated system (Bactec, Becton Dickinson, USA) and isolates were transferred to blood agar and Sabouraud dextrose agar. After the germtube test, yeasts were identifi ed according to their morphology on cornmeal Tween 80 agar, colour on CHROMagar Candida (CHROMagar, France) and biochemical tests using API 20C AUX System (bioM é rieux, France).
Statistical analyses
Categorical variables were evaluated using the chi-square and 2-tailed Fisher ' s exact tests. For continuous variables the t-test was used. Variables that were found as signifi cant ( P Ͻ 0.05) in these tests were considered as candidates for multivariate analysis. Multivariable, backwards stepwise, logistic regression analyses were built to identify independent risk factors for candidemia. All statistical analyses were performed with Statistical Package for the Social Sciences (SPSS, Version 15.0, Chicago, Il, USA) and CDC software EPI INFO (version 6.0, Atlanta, GA, USA).
Results
During the study period, 83 candidemia episodes in 83 patients were identifi ed, of which 47 (56.6%) cases involved males with a mean age of 55.04 Ϯ 17.04 (18 -84) years as compared to 55.83 Ϯ 16.56 (18 -90) years of age in the control group. Thirty-three of the patients (39.7%) were hospitalized in intensive care units (ICUs), 26 (31.3%) in surgical wards and 24 (29%) were in medical wards. The median time interval between the initial hospitalization and the diagnosis of candidemia was 18 (1 -191) days.
Distribution of species causing candidemia
C. albicans was recovered from 38 (45.8%) of the patients, whereas non-Candida albicans Candida species were isolated from 45 (54.2%). Among the latter yeasts, Candida tropicalis was the most frequently isolated, followed by Candida parapsilosis , Candida glabrata and Candida kefyr . Distribution of Candida species isolated from patients with candidemia is given in Table 1 .
Risk factors associated with candidemia
Risk factors identifi ed in univariate analyses associated with the occurrence of candidemia were length of hospitalization, high ECOG scores (3 or more), presence and duration of urethral and central venous catheters (CVC), central nervous system, thoracic or abdominal surgery, previous antibiotic and antifungal therapy, RBC transfusions and total parenteral nutrition (TPN). The patients ' characteristics and risk factors for candidemia are given in Table 2 .
In multivariate analysis, the presence of a urethral catheter, previous use of antibiotics, transfusion of RBC and parenteral nutrition were found as independent risk factors associated with candidemia as presented in Table 3 .
Risk factors for candidemia due to C. albicans and non-Candida albicans Candida species
When the risk factors associated with candidemia caused by C. albicans were evaluated, it was found that signifi cant differences existed between the clinically ill patients and the controls with respect to the following factors; previous use of broad spectrum antibiotics and any antifungal agent, history of at least one of the following surgical procedures: central nervous system, thoracic or abdominal surgery, transfusion of red blood cells (RBC), high ECOG scores (more than 2), neutropenia, presence of indwelling catheters, endotracheal intubation, mechanical ventilation and TPN. Among these risk factors we found no signifi cant differences between the patients and controls in cases involving non-Candida albicans Candida species relative to surgical procedures, neutropenia, intubation and mechanical ventilation. Results of univariate analyses are given in Table 4 .
In multivariate analysis, TPN, neutropenia and surgical procedures mentioned above were identifi ed as independent risk factors for C. albicans infections, whereas TPN, previous usage of antibiotics and presence of urethral catheters were found to be important in non-Candida albicans candidemia cases. Details are presented in Tables 5 and 6.
Discussion
Distribution of species causing candidemia
In the present study we identifi ed 83 candidemia episodes in 83 patients in which C. albicans was the most common isolate (45.8%) recovered from clinical specimens. However non-Candida albicans Candida species were associated in a higher ratio (54.2%) than C. albicans when they were considered together. Among non-Candida albicans Candida Evaluation of species distribution and risk factors of candidemia 29 species, C. tropicalis was the most frequently recovered pathogen followed by C. parapsilosis , C. glabrata and C. kefyr . Although the frequency of Candida species varies according to the geographical setting, a decreasing trend in the isolation of C. albicans has been noted worldwide [2, 6, 12] .
In the ARTEMIS DISK Surveillance program conducted between 1997 and 2003, increased rates of infections caused by C. tropicalis and C. parapsilosis were observed although there were no signifi cant changes in the isolation rates of C. glabrata and C. krusei [9] . In the European Confederation of Medical Mycology (ECMM) survey, incidence rates were 14% for C. glabrata and C. parapsilosis infections, 7% for C. tropicalis and 2% for C. krusei [13, 14] .
In our study, the distribution of Candida species was generally similar to reports from European countries. An exception is the frequency of C. tropicalis which was the second most common species isolated from our cases. C. tropicalis is an important pathogen in patients with hematological malignancies and in the US, the frequency of this yeast in clinical cases apparently decreased as a result of the use of fl uconazole prophylaxis. However, in other countries, especially in Latin America and Asia-Pasifi c region, C. tropicalis is more common [2, 6, 15, 16] . Xess et al. , reported that C. tropicalis was the most frequently isolated species during a 5-year study period in North India [17] . Similarly, in a retrospective investigation conducted in one of our study hospitals between 2000 and 2003, C. tropicalis was the most common non-Candida albicans Candida species (20.2%) identifi ed, followed by C. parapsilosis (12.5%), C. guilliermondii (3.8 %) and C. glabrata (3.8%) [7] . This frequent isolation of C. tropicalis in our study population could be explained, in part, by the lower ratio of patients receiving fl uconazole prophylaxis and geographical features [2, 6, 7] . Candida glabrata which is one of the fl uconazole resistant non-Candida albicans Candida species was responsible for only four candidemia episodes in our patients. This species has emerged as an important fungal pathogen in the US accounting for 20 -24% of all Candida BSIs [2]. In contrast, in most surveys from European countries and from Latin America, lower frequencies of C. glabrata infections were reported [6, 15, 18] . In two reports from our country, C. glabrata was isolated from 5% and 8.8% of patients hospitalized in tertiary care hospitals [19, 20] . The reasons for these different frequencies in different countries are not clear but may include exposure to azoles, patients ' age, geographical features and the sensitivity of blood culture media used in the study [2, 6, 8] .
Risk factors associated with candidemia
Risk factors involved in candidemia can be divided into (i) host-related factors such as chronic renal failure, diabetes mellitus, trauma or other immunocompromising conditions and (ii) healthcare-related factors such as hospitalization in the ICU, presence of CVCs, parenteral nutrition, antibiotic therapy, antifungal prophylaxis or surgical procedures [1] . In our patients, presence of urethral catheterization, previous use of antibiotics, RBC transfusions and TPN were identifi ed as independent risk factors of candidemia. However, unlike other studies in the literature, we did not fi nd length of hospitalization, CVC use, colonization with Candida spp., hemodialysis, antifungal prophylaxis, mechanical ventilation, neutropenia or trauma as independent risk factors [4,21 -23] . Besides previously described host-related risk factors such as chronic underlying diseases or immunocompromising conditions, we found no statistically signifi cant differences with respect to underlying patient conditions between cases and controls [1, 22] . It is interesting that use of CVCs was not found to be an independent risk factor in our study. We concluded that risk factors associated with candidemia could be related to the causative agents. In our study C. albicans was the most common pathogen followed by C. tropicalis . Candida parapsilosis known as an agent of catheter-related fungemia was not common (14.5 %) and moreover, 60.3 % of our patients were hospitalized out of the ICU where CVCs are infrequently used.
Risk factors for candidemia due to C. albicans and non-Candida albicans species
When we performed multivariate analyses of risk factors for BSIs caused by C. albicans and non-Candida albicans Candida species, TPN was an independent risk factor for candidemia caused these yeasts ( P Ͻ 0.001). Additionally, an increased risk of C. albicans BSIs was independently associated with neutropenia ( P ϭ 0.001) and surgical procedures ( P ϭ 0.04) whereas previous antibiotic use ( P ϭ 0.03) and urethral catheterization ( P ϭ 0.03) were associated with an increased risk of developing non-Candida albicans Candida candidemia. However some risk factors such as neutropenia and usage of antifungal drugs were rare in our study population. For that reason we were not confi dent to evaluate them as statistically signifi cant or not. In a 5-year review of fungemia in Thailand, authors found that former bacteremia and presence of fungal colonization were signifi cantly more common in patients with C. albicans candidemia than those with non-Candida albicans Candida candidemia [16] . In a prospective study performed in the ICU of a tertiary care hospital in Athens, the authors noted that administration of glucocorticoids, presence of CVCs and candiduria were independent risk factors with respect to candidemia caused by non-Candida albicans Candida species [24] . Chow et al . reported that ICU patients having major surgical operations, gastrointestinal procedures, enteric bacteremia, duration of TPN, number of hemodialysis days and RBC transfusions were associated with non -Candida albicans Candida candidemia [25] . For C. albicans candidemia major surgery, enteric bacteremia, TPN duration and number of hemodialysis days were independent risk factors in this study. In a prospective nationwide study reported from Australia, former exposure of antifungal drugs, gastrointestinal surgical procedures, increasing age and intravenous drug use were found to be associated with non-Candida albicans Candida candidiemia. Most common non-Candida albicans Candida species isolated in this study was C. glabrata and this could be an explanation for risk factor about age [26] .
There are numerous studies investigating epidemiology and risk factors of candidemia in the English literature. However, most of them have been conducted in ICUs or hematology/oncology units and patients involved in these studies had some specifi c underlying conditions such as hematological or solid malignancies. Some of these studies included patients with only candidemia and analyses of risk factors or prognostic indicators were conducted without control groups. For these reasons, results from these studies could be different in terms of risk factors. In our study we selected at least two control patients for each cases hospitalized in the same hospital ward in order to compare risk factors for candidemia. To our knowledge this is the fi rst case-control and multicenter study investigating the epidemiology and risk factors of candidemia from Turkey.
Our study has some limitations. Possible predisposing conditions such as hemopoietic stem cell or solid organ transplantation, malignancy, trauma, intravenous drug abuse and renal failure were rare and these factors were not found to be independently related to candidemia despite the fact that they had been defi ned in previous studies. Additionally, we could not investigate the distribution of Candida species in these specifi c conditions. Furthermore, we did not perform long-term follow up investigations of the patients after diagnosis of candidemia. Therefore we cannot provide conclusions about mortality rates of different Candida species and risk factors affecting mortality. We observed that the most common cause of candidemia was C. albicans in our patient group. Non-Candida albicans Candida species were more frequent etiologic agents than C. albicans when they were considered together. The most common non-Candida albicans Candida species was C. tropicalis . Additionally species known to be more resistant to antifungal agents such as C. glabrata were rare. Important risk factors for candidemia were invasive procedures and therapeutic interventions such as urethral catheterization, parenteral nutrition, transfusion of RBC and usage of antimicrobial agents. We conclude that a great number of candidemias are preventable infections by reducing unnecessary invasive procedures or antimicrobials. However, further prospective studies with greater number of patients belonging to different risk groups should be planned in order to investigate the factors associated with infections caused by each Candida species.
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